Atlas Trials

KN026 Combined With KN046 in Subjects With HER2 Positive Solid Tumor

Clinical trial NCT04040699 · COMPLETED

Trial details

NCT number
NCT04040699
Sponsor
Peking University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HER2 Positive Solid Tumor
Start date
2019-09-26
Primary completion
2022-09-22
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.